EdgeRock Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14
Closed -$289 225
2024
Q2
$289 Buy
+14
New +$278 ﹤0.01% 282
2024
Q1
Sell
-16
Closed -$266 239
2023
Q4
$266 Buy
+16
New +$218 ﹤0.01% 318
2022
Q4
Sell
-16
Closed 278
2022
Q3
$0 Buy
+16
New +$483 ﹤0.01% 413

Other funds holding OGN

EdgeRock Capital's OGN Position: Q3 2024 in Review

EdgeRock Capital sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 14 shares — an estimated $289 sold.

EdgeRock Capital first reported a position in OGN in Q3 2022 and held it in 3 quarters. The position peaked at $289 in Q2 2024. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • EdgeRock Capital reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
  • EdgeRock Capital sold 14 Organon & Co shares in Q3 2024, an estimated $289.
  • EdgeRock Capital first reported a position in Organon & Co in Q3 2022 and held it in 3 quarters.
  • EdgeRock Capital's Organon & Co position peaked at $289 in Q2 2024.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on EdgeRock Capital's 13F filing for Q3 2024, filed 15 Oct 2024.